SE0401762D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0401762D0 SE0401762D0 SE0401762A SE0401762A SE0401762D0 SE 0401762 D0 SE0401762 D0 SE 0401762D0 SE 0401762 A SE0401762 A SE 0401762A SE 0401762 A SE0401762 A SE 0401762A SE 0401762 D0 SE0401762 D0 SE 0401762D0
- Authority
- SE
- Sweden
- Prior art keywords
- novel compounds
- pharmaceutical compositions
- therapy
- preparing
- processes
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Priority Applications (33)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401762A SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Novel compounds |
UAA200613009A UA86977C2 (ru) | 2004-07-05 | 2005-04-07 | Производные гидантоина для лечения обструктивных болезней дыхательных путей |
TW094121763A TWI353985B (en) | 2004-07-05 | 2005-06-29 | Novel compounds |
SA05260192A SA05260192B1 (ar) | 2004-07-05 | 2005-06-29 | مشتقات Hydantoin جديدة وعمليات لتحضيرها وتركيبات صيدلانية تحتوي عليها واستخداماتها |
MYPI20053029A MY145613A (en) | 2004-07-05 | 2005-07-01 | Novel compounds |
PL05756403T PL1778673T3 (pl) | 2004-07-05 | 2005-07-04 | Nowe pochodne hydantoiny do leczenia obturacyjnych chorób dróg oddechowych |
EP05756403A EP1778673B1 (en) | 2004-07-05 | 2005-07-04 | Novel hydantoin derivatives for the treatment of obstructive airway diseases |
DE602005017636T DE602005017636D1 (de) | 2004-07-05 | 2005-07-04 | Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen |
BRPI0512974-5A BRPI0512974A (pt) | 2004-07-05 | 2005-07-04 | novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas |
RU2007101236/04A RU2386629C2 (ru) | 2004-07-05 | 2005-07-04 | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей |
SI200530892T SI1778673T1 (sl) | 2004-07-05 | 2005-07-04 | Novi hidantoinski derivati za zdravljenje obstrukcijskih bolezni dihalnih poti |
PT05756403T PT1778673E (pt) | 2004-07-05 | 2005-07-04 | Novos derivados de hidantoína para o tratamento de doenças obstrutivas das vias respiratórias |
AU2005260142A AU2005260142B2 (en) | 2004-07-05 | 2005-07-04 | Novel hydantoin derivatives for the treatment of obstructive airway diseases |
KR1020077000186A KR101222736B1 (ko) | 2004-07-05 | 2005-07-04 | 폐쇄성 기도 질환의 치료를 위한 신규 히단토인 유도체 |
NZ552101A NZ552101A (en) | 2004-07-05 | 2005-07-04 | Novel hydantoin derivatives for the treatment of obstructive airway diseases |
MXPA06014661A MXPA06014661A (es) | 2004-07-05 | 2005-07-04 | Derivados de hidantoina novedosos para el tratamiento de enfermedades de las vias respiratorias obstructivas. |
DK05756403.1T DK1778673T3 (da) | 2004-07-05 | 2005-07-04 | Nye hydantoin-derivater til behandling af obstruktive luftvejssygdomme |
CA2569716A CA2569716C (en) | 2004-07-05 | 2005-07-04 | Hydantoin derivatives for the treatment of obstructive airway diseases |
ES05756403T ES2335424T3 (es) | 2004-07-05 | 2005-07-04 | Nuevos derivados de hidantoina para el tratamiento de enfermedades obstructivas de las vias respiratorias. |
PCT/SE2005/001092 WO2006004532A1 (en) | 2004-07-05 | 2005-07-04 | Novel hydantoin derivatives for the treatment of obstructive airway diseases |
AT05756403T ATE448219T1 (de) | 2004-07-05 | 2005-07-04 | Neue hydantoinderivate zur behandlung von obstruktiven atemwegserkrankungen |
JP2007520267A JP4390833B2 (ja) | 2004-07-05 | 2005-07-04 | 閉塞性気道疾患の処置のための新規ヒダントイン誘導体 |
RSP-2010/0038A RS51280B (sr) | 2004-07-05 | 2005-07-04 | Novi derivati hidantoina za tretman obstruktivnih bolesti dišnih puteva |
CNB2005800228017A CN100543024C (zh) | 2004-07-05 | 2005-07-04 | 用于治疗阻塞性气道疾病的乙内酰脲衍生物 |
UY29002A UY29002A1 (es) | 2004-07-05 | 2005-07-05 | Nuevos derivados de hidantoína, procesos parasu preparación, composiciones farmacéuticas que los contienen y su uso en terapia |
ARP050102793A AR049578A1 (es) | 2004-07-05 | 2005-07-05 | Derivados de hidantoina, procesos de obtencion y composiciones farmaceuticas |
IL179906A IL179906A (en) | 2004-07-05 | 2006-12-07 | Hydantoin derivatives, process for their preparation, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of obstructive airway diseases |
ZA200610698A ZA200610698B (en) | 2004-07-05 | 2006-12-19 | Novel hydantoin derivatives for the treatment of obstructive airway diseases |
NO20070576A NO20070576L (no) | 2004-07-05 | 2007-01-30 | Nye hydantionderivater for behandling av obstruktive luftveissykdommer. |
HK07111163.1A HK1102814A1 (en) | 2004-07-05 | 2007-10-17 | Novel hydantoin derivatives for the treatment of obstructive airway diseases |
US12/629,630 US7989620B2 (en) | 2004-07-05 | 2009-12-02 | Hydantoin derivatives for the treatment of obstructive airway diseases |
HR20100020T HRP20100020T1 (hr) | 2004-07-05 | 2010-01-11 | Novi derivati hidantoina za liječenje opstruktivnih bolesti dišnih putova |
CY20101100026T CY1109728T1 (el) | 2004-07-05 | 2010-01-11 | Νεα παραγωγα υδαντοϊνης για τη θεραπεια αποφρακτικων νοσηματων της αναπνευστικης οδου |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0401762A SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0401762D0 true SE0401762D0 (sv) | 2004-07-05 |
Family
ID=32768773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0401762A SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Novel compounds |
Country Status (33)
Country | Link |
---|---|
US (1) | US7989620B2 (sv) |
EP (1) | EP1778673B1 (sv) |
JP (1) | JP4390833B2 (sv) |
KR (1) | KR101222736B1 (sv) |
CN (1) | CN100543024C (sv) |
AR (1) | AR049578A1 (sv) |
AT (1) | ATE448219T1 (sv) |
AU (1) | AU2005260142B2 (sv) |
BR (1) | BRPI0512974A (sv) |
CA (1) | CA2569716C (sv) |
CY (1) | CY1109728T1 (sv) |
DE (1) | DE602005017636D1 (sv) |
DK (1) | DK1778673T3 (sv) |
ES (1) | ES2335424T3 (sv) |
HK (1) | HK1102814A1 (sv) |
HR (1) | HRP20100020T1 (sv) |
IL (1) | IL179906A (sv) |
MX (1) | MXPA06014661A (sv) |
MY (1) | MY145613A (sv) |
NO (1) | NO20070576L (sv) |
NZ (1) | NZ552101A (sv) |
PL (1) | PL1778673T3 (sv) |
PT (1) | PT1778673E (sv) |
RS (1) | RS51280B (sv) |
RU (1) | RU2386629C2 (sv) |
SA (1) | SA05260192B1 (sv) |
SE (1) | SE0401762D0 (sv) |
SI (1) | SI1778673T1 (sv) |
TW (1) | TWI353985B (sv) |
UA (1) | UA86977C2 (sv) |
UY (1) | UY29002A1 (sv) |
WO (1) | WO2006004532A1 (sv) |
ZA (1) | ZA200610698B (sv) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100902D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401763D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Compounds |
SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
US7776869B2 (en) * | 2004-10-18 | 2010-08-17 | Amgen Inc. | Heteroaryl-substituted alkyne compounds and method of use |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
TW200740769A (en) | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
TW200831488A (en) * | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
GB0702456D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
WO2009007747A2 (en) * | 2007-07-11 | 2009-01-15 | Astrazeneca Ab | Hydantoin derivatives used as mmp12 inhibitors |
GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
WO2011073662A1 (en) | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Combination of a benzoxazinone and a further agent for treating respiratory diseases |
GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
EP2907512A1 (en) | 2014-02-14 | 2015-08-19 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Inhibitors of MMP-12 as antiviral Agents |
RU2555341C1 (ru) * | 2014-04-29 | 2015-07-10 | Федеральное бюджетное учреждение науки "Федеральный научный центр медико-профилактических технологий управления рисками здоровью населения" (ФБУН "ФНЦ медико-профилактических технологий управления рисками здоровью населения") | Способ профилактики развития у детей старше 5 лет неконтролируемых форм бронхиальной астмы, обусловленных воздействием марганца и ванадия |
KR20170107536A (ko) | 2015-01-30 | 2017-09-25 | 바스프 에스이 | 제초 페닐피리미딘 |
CN109561685A (zh) | 2016-07-25 | 2019-04-02 | 巴斯夫欧洲公司 | 除草的嘧啶化合物 |
AU2017302980A1 (en) | 2016-07-25 | 2019-01-03 | Basf Se | Herbicidal pyrimidine compounds |
CA3064513A1 (en) | 2017-06-14 | 2018-12-20 | Basf Se | Herbicidal pyrimidine compounds |
WO2019121408A1 (en) | 2017-12-20 | 2019-06-27 | Basf Se | Herbicidal pyrimidine compounds |
JP7365393B2 (ja) | 2018-07-16 | 2023-10-19 | ヘパリジェニックス ゲーエムベーハー | 肝再生促進又は肝細胞死の抑制もしくは防止のためのプロテインキナーゼ阻害剤 |
CA3112955A1 (en) | 2018-09-19 | 2020-03-26 | Bayer Aktiengesellschaft | Herbicidally active substituted phenylpyrimidine hydrazides |
WO2021260387A1 (en) | 2020-06-26 | 2021-12-30 | The University Of Birmingham | Mmp-9 and mmp-12 inhibition for treating spinal cord injury or related injury to neurological tissue |
Family Cites Families (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2327890A (en) | 1940-04-17 | 1943-08-24 | Parke Davis & Co | Substituted phenoxyalkyl ethers |
US2745875A (en) | 1953-06-30 | 1956-05-15 | Hoechst Ag | Preparation of nu-acylamino-phenylpropane diols |
US3452040A (en) | 1966-01-05 | 1969-06-24 | American Home Prod | 5,5-disubstituted hydantoins |
US3529019A (en) | 1968-04-23 | 1970-09-15 | Colgate Palmolive Co | Alkylaryloxy alanines |
US3849574A (en) | 1971-05-24 | 1974-11-19 | Colgate Palmolive Co | Alpha-substituted-beta-arylthioalkyl amino-acids,for increasing heart rate |
US4315031A (en) | 1977-09-01 | 1982-02-09 | Science Union Et Cie | Thiosubstituted amino acids |
GB1601310A (en) | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
JPS6172762A (ja) | 1984-09-17 | 1986-04-14 | Kanegafuchi Chem Ind Co Ltd | 光学活性ヒダントイン類の製造法 |
JPS61212292A (ja) | 1985-03-19 | 1986-09-20 | Mitsui Toatsu Chem Inc | D−α−アミノ酸の製造方法 |
CA1325222C (en) | 1985-08-23 | 1993-12-14 | Lederle (Japan), Ltd. | Process for producing 4-biphenylylacetic acid |
GB8618559D0 (en) | 1986-07-30 | 1986-09-10 | Genetics Int Inc | Rhodococcus bacterium |
US4983771A (en) | 1989-09-18 | 1991-01-08 | Hexcel Corporation | Method for resolution of D,L-alpha-phenethylamine with D(-)mandelic acid |
NL9000386A (nl) | 1990-02-16 | 1991-09-16 | Stamicarbon | Werkwijze voor de bereiding van optisch aktief aminozuuramide. |
DK161690D0 (da) | 1990-07-05 | 1990-07-05 | Novo Nordisk As | Fremgangsmaade til fremstilling af enantiomere forbindelser |
IL99957A0 (en) | 1990-11-13 | 1992-08-18 | Merck & Co Inc | Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them |
PH31245A (en) | 1991-10-30 | 1998-06-18 | Janssen Pharmaceutica Nv | 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives. |
US5308853A (en) | 1991-12-20 | 1994-05-03 | Warner-Lambert Company | Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties |
US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
NL9201230A (nl) | 1992-07-09 | 1994-02-01 | Dsm Nv | Werkwijze voor de bereiding van optisch aktief methionineamide. |
EP0640594A1 (en) | 1993-08-23 | 1995-03-01 | Fujirebio Inc. | Hydantoin derivative as metalloprotease inhibitor |
JPH09505310A (ja) | 1993-11-16 | 1997-05-27 | メルク エンド カンパニー インコーポレーテッド | ピペリジンショウノウスルホニルオキシトシン拮抗剤 |
EP0709375B1 (en) | 1994-10-25 | 2005-05-18 | AstraZeneca AB | Therapeutic heterocycles |
ZA96211B (en) | 1995-01-12 | 1996-07-26 | Teva Pharma | Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
US6166041A (en) | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
WO1997019075A1 (en) | 1995-11-22 | 1997-05-29 | Darwin Discovery Limited | Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf) |
GB9616643D0 (en) | 1996-08-08 | 1996-09-25 | Chiroscience Ltd | Compounds |
US5919790A (en) | 1996-10-11 | 1999-07-06 | Warner-Lambert Company | Hydroxamate inhibitors of interleukin-1β converting enzyme |
ATE212619T1 (de) | 1996-10-22 | 2002-02-15 | Upjohn Co | Alpha-amino sulfonyl hydroxamsäure als matrix metalloproteinase inhibitoren |
HUP0003362A3 (en) | 1997-05-06 | 2001-04-28 | Novo Nordisk As | Piperidine derivatives and pharmaceutical compositions containing them |
DE59802394D1 (de) | 1997-05-09 | 2002-01-24 | Hoechst Ag | Substituierte Diaminocarbonsäuren |
TR199903287T2 (xx) | 1997-07-31 | 2000-09-21 | Abbott Laboratories | Matriks metaloproteinazlar�n�n ters hidroksamat inhibit�rleri. |
TW514634B (en) | 1997-10-14 | 2002-12-21 | Lilly Co Eli | Process to make chiral compounds |
KR100609926B1 (ko) | 1997-11-12 | 2006-08-04 | 다윈 디스커버리 리미티드 | 엠엠피와 티엔에프 억제 활성을 갖는 히드록삼산 및카르복실산 유도체 |
KR20010040698A (ko) | 1998-02-04 | 2001-05-15 | 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 | 기질 분해 메탈로프로테이나제를 억제하는 술포닐아미노유도체 |
US6329418B1 (en) | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
AU4074799A (en) | 1998-05-14 | 1999-11-29 | Du Pont Pharmaceuticals Company | Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
JP2002516904A (ja) | 1998-06-03 | 2002-06-11 | ジーピーアイ ニル ホールディングス インコーポレイテッド | N−複素環式カルボン酸またはカルボン酸等配電子体のn−結合スルホンアミド |
JP2002518368A (ja) | 1998-06-17 | 2002-06-25 | デュポン ファーマシューティカルズ カンパニー | メタロプロテイナーゼ阻害剤としての環式ヒドロキサム酸類 |
FR2782082B3 (fr) | 1998-08-05 | 2000-09-22 | Sanofi Sa | Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose |
US6339101B1 (en) | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
DE69907238T2 (de) | 1998-10-07 | 2003-11-06 | Yazaki Corp | Sol-gel verfahren unter verwendung poröser formen |
DK1004578T3 (da) | 1998-11-05 | 2004-06-28 | Pfizer Prod Inc | 5-oxo-pyrrolidin-2-carboxylsyrehydroxamidderivater |
US6340691B1 (en) | 1999-01-27 | 2002-01-22 | American Cyanamid Company | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
WO2000044770A1 (fr) | 1999-01-28 | 2000-08-03 | Chugai Seiyaku Kabushiki Kaisha | Derives phenethylamine substitues |
US20020006920A1 (en) | 1999-07-22 | 2002-01-17 | Robinson Ralph Pelton | Arylsulfonylamino hydroxamic acid derivatives |
DE60026404T2 (de) | 1999-08-02 | 2006-10-19 | F. Hoffmann-La Roche Ag | Verfahren zur Herstellung von Benzothiophen-Derivaten |
EA005373B1 (ru) | 1999-08-12 | 2005-02-24 | Фармация Италия С.П.А. | Производные 3(5)-аминопиразола, способ их получения и их применение в качестве противоопухолевых средств |
US6283379B1 (en) * | 2000-02-14 | 2001-09-04 | Kic Thermal Profiling | Method for correlating processor and part temperatures using an air temperature sensor for a conveyorized thermal processor |
US6525202B2 (en) | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
US20020065219A1 (en) | 2000-08-15 | 2002-05-30 | Naidu B. Narasimhulu | Water soluble thiazolyl peptide derivatives |
US20020091107A1 (en) | 2000-09-08 | 2002-07-11 | Madar David J. | Oxazolidinone antibacterial agents |
EP1191024A1 (en) | 2000-09-22 | 2002-03-27 | Harald Tschesche | Thiadiazines and their use as inhibitors of metalloproteinases |
BR0208105A (pt) * | 2001-03-15 | 2004-03-09 | Astrazeneca Ab | Inibidores de metaloproteinase |
SE0100903D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
CA2447475A1 (en) | 2001-05-25 | 2002-12-05 | Chu-Biao Xue | Hydantion derivatives as inhibitors of matrix metalloproteinases |
GB0114004D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
SE0103710D0 (sv) | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
KR20050010826A (ko) | 2002-06-05 | 2005-01-28 | 가부시키가이샤 가네카 | 광학 활성 α-메틸시스테인 유도체의 제조 방법 |
SE0202539D0 (sv) | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
GB0221250D0 (en) | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
US20040266832A1 (en) | 2003-06-26 | 2004-12-30 | Li Zheng J. | Crystal forms of 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl pyridine |
TWI220073B (en) | 2003-07-24 | 2004-08-01 | Au Optronics Corp | Method for manufacturing polysilicon film |
SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
SE0401763D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0403085D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
TW200800954A (en) | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
TW200740769A (en) | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
TW200831488A (en) | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
-
2004
- 2004-07-05 SE SE0401762A patent/SE0401762D0/sv unknown
-
2005
- 2005-04-07 UA UAA200613009A patent/UA86977C2/ru unknown
- 2005-06-29 TW TW094121763A patent/TWI353985B/zh not_active IP Right Cessation
- 2005-06-29 SA SA05260192A patent/SA05260192B1/ar unknown
- 2005-07-01 MY MYPI20053029A patent/MY145613A/en unknown
- 2005-07-04 DE DE602005017636T patent/DE602005017636D1/de active Active
- 2005-07-04 CN CNB2005800228017A patent/CN100543024C/zh active Active
- 2005-07-04 PT PT05756403T patent/PT1778673E/pt unknown
- 2005-07-04 AU AU2005260142A patent/AU2005260142B2/en not_active Ceased
- 2005-07-04 CA CA2569716A patent/CA2569716C/en not_active Expired - Fee Related
- 2005-07-04 JP JP2007520267A patent/JP4390833B2/ja active Active
- 2005-07-04 NZ NZ552101A patent/NZ552101A/en not_active IP Right Cessation
- 2005-07-04 ES ES05756403T patent/ES2335424T3/es active Active
- 2005-07-04 RU RU2007101236/04A patent/RU2386629C2/ru not_active IP Right Cessation
- 2005-07-04 MX MXPA06014661A patent/MXPA06014661A/es active IP Right Grant
- 2005-07-04 WO PCT/SE2005/001092 patent/WO2006004532A1/en active Application Filing
- 2005-07-04 KR KR1020077000186A patent/KR101222736B1/ko not_active IP Right Cessation
- 2005-07-04 BR BRPI0512974-5A patent/BRPI0512974A/pt active Search and Examination
- 2005-07-04 EP EP05756403A patent/EP1778673B1/en active Active
- 2005-07-04 DK DK05756403.1T patent/DK1778673T3/da active
- 2005-07-04 AT AT05756403T patent/ATE448219T1/de active
- 2005-07-04 RS RSP-2010/0038A patent/RS51280B/sr unknown
- 2005-07-04 SI SI200530892T patent/SI1778673T1/sl unknown
- 2005-07-04 PL PL05756403T patent/PL1778673T3/pl unknown
- 2005-07-05 AR ARP050102793A patent/AR049578A1/es not_active Application Discontinuation
- 2005-07-05 UY UY29002A patent/UY29002A1/es not_active Application Discontinuation
-
2006
- 2006-12-07 IL IL179906A patent/IL179906A/en not_active IP Right Cessation
- 2006-12-19 ZA ZA200610698A patent/ZA200610698B/en unknown
-
2007
- 2007-01-30 NO NO20070576A patent/NO20070576L/no not_active Application Discontinuation
- 2007-10-17 HK HK07111163.1A patent/HK1102814A1/xx not_active IP Right Cessation
-
2009
- 2009-12-02 US US12/629,630 patent/US7989620B2/en active Active
-
2010
- 2010-01-11 CY CY20101100026T patent/CY1109728T1/el unknown
- 2010-01-11 HR HR20100020T patent/HRP20100020T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0401762D0 (sv) | Novel compounds | |
TW200801003A (en) | Novel compounds | |
SE0200920D0 (sv) | Novel compounds | |
TW200800999A (en) | Novel compounds | |
SE0302811D0 (sv) | Novel compounds | |
TW200605888A (en) | Novel compounds | |
SE0202539D0 (sv) | Compounds | |
TW200738659A (en) | Novel compounds | |
SE0301700D0 (sv) | Novel compounds | |
TW200635917A (en) | Novel compounds | |
TW200745084A (en) | Novel compounds | |
SE0104140D0 (sv) | Novel Compounds | |
TW200613243A (en) | Novel compounds | |
TW200745114A (en) | Novel compounds | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
TW200621262A (en) | New dihydropteridione derivatives, process for their manufacture and their use as medicament | |
TW200635916A (en) | Compounds | |
SE0202133D0 (sv) | Novel compounds | |
EA201190235A1 (ru) | Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750 | |
TW200833670A (en) | Novel compounds 569 | |
SE0300480D0 (sv) | Novel compounds | |
MX2010009022A (es) | Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso. | |
TW200639156A (en) | New compounds | |
TW200745122A (en) | New compounds I | |
TW200740781A (en) | Novel compounds |